CRISPR-Cas-amplified urine biomarkers for multiplexed and portable cancer diagnostics
L. Hao, R. T. Zhao, C. Ngambenjawong, H. E. Fleming, S. Bhatia
This paper develops CRISPR-Cas-amplified urine biomarkers for noninvasive cancer detection and monitoring in murine models.
bioRxiv · Jun 17, 2020 · PreprintBioengineering